APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Gastro-retentive Drug Delivery System

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Gastro-retentive Drug Delivery System Market Analysis and Forecast 2026-2032

Report ID 17414821023 May 2026253 pages

Choose your research edition.

Industry ResearchGastro-retentive Drug Delivery System Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastro-retentive Drug Delivery System Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Gastro-retentive Drug Delivery System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastro-retentive Drug Delivery System Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastro-retentive Drug Delivery System Market Analysis and Forecast 2026-2032253 pages · $4,950 USD

Market perspective

The global Gastro-retentive Drug Delivery System market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Gastro-retentive Drug Delivery System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Gastro-retentive Drug Delivery System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Gastro-retentive Drug Delivery System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Gastro-retentive Drug Delivery System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Gastro-retentive Drug Delivery System include Triastek, Inc., Bostal Drug Delivery Co., Ltd., Vivtex Corporation, Clexio Biosciences Ltd., Medimetrics Personalized Drug Delivery, Inc., Lonza Group AG, Catalent, Inc., Evonik Industries AG and Colorcon, Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Gastro-retentive Drug Delivery System, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Gastro-retentive Drug Delivery System, also provides the revenue of main regions and countries. Of the upcoming market potential for Gastro-retentive Drug Delivery System, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gastro-retentive Drug Delivery System revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gastro-retentive Drug Delivery System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Gastro-retentive Drug Delivery System revenue, projected growth trends, production technology, application and end-user industry.

Gastro-retentive Drug Delivery System Segment by Company

Triastek, Inc.

Bostal Drug Delivery Co., Ltd.

Vivtex Corporation

Clexio Biosciences Ltd.

Medimetrics Personalized Drug Delivery, Inc.

Lonza Group AG

Catalent, Inc.

Evonik Industries AG

Colorcon, Inc.

Quotient Sciences

AbbVie Inc.

AstraZeneca plc

GlaxoSmithKline plc (GSK)

Novartis AG

Pfizer Inc.

Sanofi S.A.

Sun Pharmaceutical Industries Ltd.

Lupin Limited

Dr. Reddy's Laboratories Ltd.

Cipla Ltd.

Gastro-retentive Drug Delivery System Segment by Type

Sustained Release

Controlled Release (Zero-Order)

Delayed / Pulsatile Release

Gastro-retentive Drug Delivery System Segment by Application

Anti-infective (H. pylori Eradication)

Gastroenterology (Peptic Ulcer, GERD)

Metabolic Disorders (Diabetes)

Cardiovascular (Hypertension)

Antiviral Therapy

Gastro-retentive Drug Delivery System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastro-retentive Drug Delivery System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastro-retentive Drug Delivery System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastro-retentive Drug Delivery System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Gastro-retentive Drug Delivery System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Gastro-retentive Drug Delivery System company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gastro-retentive Drug Delivery System revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gastro-retentive Drug Delivery System Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Sustained Release Major Player Table 3. Controlled Release (Zero-Order) Major Player Table 4. Delayed / Pulsatile Release Major Player Table 5. Global Gastro-retentive Drug Delivery System Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Anti-infective (H. pylori Eradication) Major Player Table 7. Gastroenterology (Peptic Ulcer, GERD) Major Player Table 8. Metabolic Disorders (Diabetes) Major Player Table 9. Cardiovascular (Hypertension) Major Player Table 10. Antiviral Therapy Major Player Table 11. Gastro-retentive Drug Delivery System Industry Trends Table 12. Gastro-retentive Drug Delivery System Industry Drivers Table 13. Gastro-retentive Drug Delivery System Industry Opportunities and Challenges Table 14. Gastro-retentive Drug Delivery System Industry Restraints Table 15. Global Gastro-retentive Drug Delivery System Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Gastro-retentive Drug Delivery System Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Gastro-retentive Drug Delivery System Market Share by Region (2021-2026) Table 18. Global Gastro-retentive Drug Delivery System Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Gastro-retentive Drug Delivery System Market Share by Region (2027-2032) Table 20. Global Gastro-retentive Drug Delivery System Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Gastro-retentive Drug Delivery System Revenue Market Share by Players (2021-2026) Table 22. Global Gastro-retentive Drug Delivery System Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Gastro-retentive Drug Delivery System Key Players Headquarters & Area Served Table 24. Global Gastro-retentive Drug Delivery System Players, Product Type & Application Table 25. Global Gastro-retentive Drug Delivery System Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Gastro-retentive Drug Delivery System by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Gastro-retentive Drug Delivery System Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Gastro-retentive Drug Delivery System Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Gastro-retentive Drug Delivery System Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Gastro-retentive Drug Delivery System Revenue Market Share by Type (2021-2026) Table 32. Global Gastro-retentive Drug Delivery System Revenue Market Share by Type (2027-2032) Table 33. Global Gastro-retentive Drug Delivery System Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Gastro-retentive Drug Delivery System Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Gastro-retentive Drug Delivery System Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Gastro-retentive Drug Delivery System Revenue Market Share by Application (2021-2026) Table 37. Global Gastro-retentive Drug Delivery System Revenue Market Share by Application (2027-2032) Table 38. Triastek, Inc. Company Information Table 39. Triastek, Inc. Business Overview Table 40. Triastek, Inc. Gastro-retentive Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Triastek, Inc. Gastro-retentive Drug Delivery System Product Portfolio Table 42. Triastek, Inc. Recent Development Table 43. Bostal Drug Delivery Co., Ltd. Company Information Table 44. Bostal Drug Delivery Co., Ltd. Business Overview Table 45. Bostal Drug Delivery Co., Ltd. Gastro-retentive Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Bostal Drug Delivery Co., Ltd. Gastro-retentive Drug Delivery System Product Portfolio Table 47. Bostal Drug Delivery Co., Ltd. Recent Development Table 48. Vivtex Corporation Company Information Table 49. Vivtex Corporation Business Overview Table 50. Vivtex Corporation Gastro-retentive Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Vivtex Corporation Gastro-retentive Drug Delivery System Product Portfolio Table 52. Vivtex Corporation Recent Development Table 53. Clexio Biosciences Ltd. Company Information Table 54. Clexio Biosciences Ltd. Business Overview Table 55. Clexio Biosciences Ltd. Gastro-retentive Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Clexio Biosciences Ltd. Gastro-retentive Drug Delivery System Product Portfolio Table 57. Clexio Biosciences Ltd. Recent Development Table 58. Medimetrics Personalized Drug Delivery, Inc. Company Information Table 59. Medimetrics Personalized Drug Delivery, Inc. Business Overview Table 60. Medimetrics Personalized Drug Delivery, Inc. Gastro-retentive Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Medimetrics Personalized Drug Delivery, Inc. Gastro-retentive Drug Delivery System Product Portfolio Table 62. Medimetrics Personalized Drug Delivery, Inc. Recent Development Table 63. Lonza Group AG Company Information Table 64. Lonza Group AG Business Overview Table 65. Lonza Group AG Gastro-retentive Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Lonza Group AG Gastro-retentive Drug Delivery System Product Portfolio Table 67. Lonza Group AG Recent Development Table 68. Catalent, Inc. Company Information Table 69. Catalent, Inc. Business Overview Table 70. Catalent, Inc. Gastro-retentive Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Catalent, Inc. Gastro-retentive Drug Delivery System Product Portfolio Table 72. Catalent, Inc. Recent Development Table 73. Evonik Industries AG Company Information Table 74. Evonik Industries AG Business Overview Table 75. Evonik Industries AG Gastro-retentive Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Evonik Industries AG Gastro-retentive Drug Delivery System Product Portfolio Table 77. Evonik Industries AG Recent Development Table 78. Colorcon, Inc. Company Information Table 79. Colorcon, Inc. Business Overview Table 80. Colorcon, Inc. Gastro-retentive Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Colorcon, Inc. Gastro-retentive Drug Delivery System Product Portfolio Table 82. Colorcon, Inc. Recent Development Table 83. Quotient Sciences Company Information Table 84. Quotient Sciences Business Overview Table 85. Quotient Sciences Gastro-retentive Drug Delivery System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Quotient Sciences Gastro-retentive Drug Delivery System Product Portfolio Table 87. Quotient Sciences Recent Development Table 88. AbbVie Inc. Company Information Table 89. AbbVie Inc. Business Overview Table 90. AbbVie Inc. Gastro-retentive Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. AbbVie Inc. Gastro-retentive Drug Delivery System Product Portfolio Table 92. AbbVie Inc. Recent Development Table 93. AstraZeneca plc Company Information Table 94. AstraZeneca plc Business Overview Table 95. AstraZeneca plc Gastro-retentive Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. AstraZeneca plc Gastro-retentive Drug Delivery System Product Portfolio Table 97. AstraZeneca plc Recent Development Table 98. GlaxoSmithKline plc (GSK) Company Information Table 99. GlaxoSmithKline plc (GSK) Business Overview Table 100. GlaxoSmithKline plc (GSK) Gastro-retentive Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. GlaxoSmithKline plc (GSK) Gastro-retentive Drug Delivery System Product Portfolio Table 102. GlaxoSmithKline plc (GSK) Recent Development Table 103. Novartis AG Company Information Table 104. Novartis AG Business Overview Table 105. Novartis AG Gastro-retentive Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Novartis AG Gastro-retentive Drug Delivery System Product Portfolio Table 107. Novartis AG Recent Development Table 108. Pfizer Inc. Company Information Table 109. Pfizer Inc. Business Overview Table 110. Pfizer Inc. Gastro-retentive Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Pfizer Inc. Gastro-retentive Drug Delivery System Product Portfolio Table 112. Pfizer Inc. Recent Development Table 113. Sanofi S.A. Company Information Table 114. Sanofi S.A. Business Overview Table 115. Sanofi S.A. Gastro-retentive Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Sanofi S.A. Gastro-retentive Drug Delivery System Product Portfolio Table 117. Sanofi S.A. Recent Development Table 118. Sun Pharmaceutical Industries Ltd. Company Information Table 119. Sun Pharmaceutical Industries Ltd. Business Overview Table 120. Sun Pharmaceutical Industries Ltd. Gastro-retentive Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Sun Pharmaceutical Industries Ltd. Gastro-retentive Drug Delivery System Product Portfolio Table 122. Sun Pharmaceutical Industries Ltd. Recent Development Table 123. Lupin Limited Company Information Table 124. Lupin Limited Business Overview Table 125. Lupin Limited Gastro-retentive Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Lupin Limited Gastro-retentive Drug Delivery System Product Portfolio Table 127. Lupin Limited Recent Development Table 128. Dr. Reddy's Laboratories Ltd. Company Information Table 129. Dr. Reddy's Laboratories Ltd. Business Overview Table 130. Dr. Reddy's Laboratories Ltd. Gastro-retentive Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Dr. Reddy's Laboratories Ltd. Gastro-retentive Drug Delivery System Product Portfolio Table 132. Dr. Reddy's Laboratories Ltd. Recent Development Table 133. Cipla Ltd. Company Information Table 134. Cipla Ltd. Business Overview Table 135. Cipla Ltd. Gastro-retentive Drug Delivery System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. Cipla Ltd. Gastro-retentive Drug Delivery System Product Portfolio Table 137. Cipla Ltd. Recent Development Table 138. North America Gastro-retentive Drug Delivery System Revenue by Type (2021-2026) & (US$ Million) Table 139. North America Gastro-retentive Drug Delivery System Revenue by Type (2027-2032) & (US$ Million) Table 140. North America Gastro-retentive Drug Delivery System Revenue by Application (2021-2026) & (US$ Million) Table 141. North America Gastro-retentive Drug Delivery System Revenue by Application (2027-2032) & (US$ Million) Table 142. North America Gastro-retentive Drug Delivery System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. North America Gastro-retentive Drug Delivery System Revenue by Country (2021-2026) & (US$ Million) Table 144. North America Gastro-retentive Drug Delivery System Revenue by Country (US$ Million) & (2027-2032) Table 145. Europe Gastro-retentive Drug Delivery System Revenue by Type (2021-2026) & (US$ Million) Table 146. Europe Gastro-retentive Drug Delivery System Revenue by Type (2027-2032) & (US$ Million) Table 147. Europe Gastro-retentive Drug Delivery System Revenue by Application (2021-2026) & (US$ Million) Table 148. Europe Gastro-retentive Drug Delivery System Revenue by Application (2027-2032) & (US$ Million) Table 149. Europe Gastro-retentive Drug Delivery System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Europe Gastro-retentive Drug Delivery System Revenue by Country (2021-2026) & (US$ Million) Table 151. Europe Gastro-retentive Drug Delivery System Revenue by Country (US$ Million) & (2027-2032) Table 152. China Gastro-retentive Drug Delivery System Revenue by Type (2021-2026) & (US$ Million) Table 153. China Gastro-retentive Drug Delivery System Revenue by Type (2027-2032) & (US$ Million) Table 154. China Gastro-retentive Drug Delivery System Revenue by Application (2021-2026) & (US$ Million) Table 155. China Gastro-retentive Drug Delivery System Revenue by Application (2027-2032) & (US$ Million) Table 156. Asia Gastro-retentive Drug Delivery System Revenue by Type (2021-2026) & (US$ Million) Table 157. Asia Gastro-retentive Drug Delivery System Revenue by Type (2027-2032) & (US$ Million) Table 158. Asia Gastro-retentive Drug Delivery System Revenue by Application (2021-2026) & (US$ Million) Table 159. Asia Gastro-retentive Drug Delivery System Revenue by Application (2027-2032) & (US$ Million) Table 160. Asia Gastro-retentive Drug Delivery System Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 161. Asia Gastro-retentive Drug Delivery System Revenue by Region (US$ Million) & (2021-2026) Table 162. Asia Gastro-retentive Drug Delivery System Revenue by Region (US$ Million) & (2027-2032) Table 163. SAMEA Gastro-retentive Drug Delivery System Revenue by Type (2021-2026) & (US$ Million) Table 164. SAMEA Gastro-retentive Drug Delivery System Revenue by Type (2027-2032) & (US$ Million) Table 165. SAMEA Gastro-retentive Drug Delivery System Revenue by Application (2021-2026) & (US$ Million) Table 166. SAMEA Gastro-retentive Drug Delivery System Revenue by Application (2027-2032) & (US$ Million) Table 167. SAMEA Gastro-retentive Drug Delivery System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 168. SAMEA Gastro-retentive Drug Delivery System Revenue by Country (2021-2026) & (US$ Million) Table 169. SAMEA Gastro-retentive Drug Delivery System Revenue by Country (US$ Million) & (2027-2032) Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Gastro-retentive Drug Delivery System Image Figure 2. Global Gastro-retentive Drug Delivery System Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gastro-retentive Drug Delivery System Market Size Share 2021 VS 2025 VS 2032 Figure 4. Sustained Release Image Figure 5. Controlled Release (Zero-Order) Image Figure 6. Delayed / Pulsatile Release Image Figure 7. Global Gastro-retentive Drug Delivery System Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Gastro-retentive Drug Delivery System Market Size Share 2021 VS 2025 VS 2032 Figure 9. Anti-infective (H. pylori Eradication) Image Figure 10. Gastroenterology (Peptic Ulcer, GERD) Image Figure 11. Metabolic Disorders (Diabetes) Image Figure 12. Cardiovascular (Hypertension) Image Figure 13. Antiviral Therapy Image Figure 14. Global Gastro-retentive Drug Delivery System Market Size (US$ Million) & (2021-2032) Figure 15. Global Gastro-retentive Drug Delivery System Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Gastro-retentive Drug Delivery System Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Gastro-retentive Drug Delivery System Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Gastro-retentive Drug Delivery System Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Gastro-retentive Drug Delivery System Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Gastro-retentive Drug Delivery System Revenue Market Share by Type (2021-2032) Figure 22. Global Gastro-retentive Drug Delivery System Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Gastro-retentive Drug Delivery System Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Gastro-retentive Drug Delivery System Revenue Market Share by Application (2021-2032) Figure 25. North America Gastro-retentive Drug Delivery System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Gastro-retentive Drug Delivery System Revenue Share by Type (2021-2032) Figure 27. North America Gastro-retentive Drug Delivery System Revenue Share by Application (2021-2032) Figure 28. North America Gastro-retentive Drug Delivery System Revenue Share by Country (2021-2032) Figure 29. United States Gastro-retentive Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Gastro-retentive Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Gastro-retentive Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Gastro-retentive Drug Delivery System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Gastro-retentive Drug Delivery System Revenue Share by Type (2021-2032) Figure 34. Europe Gastro-retentive Drug Delivery System Revenue Share by Application (2021-2032) Figure 35. Europe Gastro-retentive Drug Delivery System Revenue Share by Country (2021-2032) Figure 36. Germany Gastro-retentive Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Gastro-retentive Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Gastro-retentive Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Gastro-retentive Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Gastro-retentive Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Gastro-retentive Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Gastro-retentive Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Gastro-retentive Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Gastro-retentive Drug Delivery System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Gastro-retentive Drug Delivery System Revenue Share by Type (2021-2032) Figure 46. China Gastro-retentive Drug Delivery System Revenue Share by Application (2021-2032) Figure 47. Asia Gastro-retentive Drug Delivery System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Gastro-retentive Drug Delivery System Revenue Share by Type (2021-2032) Figure 49. Asia Gastro-retentive Drug Delivery System Revenue Share by Application (2021-2032) Figure 50. Asia Gastro-retentive Drug Delivery System Revenue Share by Region (2021-2032) Figure 51. Japan Gastro-retentive Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Gastro-retentive Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Gastro-retentive Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Gastro-retentive Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Gastro-retentive Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Gastro-retentive Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Gastro-retentive Drug Delivery System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Gastro-retentive Drug Delivery System Revenue Share by Type (2021-2032) Figure 59. SAMEA Gastro-retentive Drug Delivery System Revenue Share by Application (2021-2032) Figure 60. SAMEA Gastro-retentive Drug Delivery System Revenue Share by Country (2021-2032) Figure 61. Brazil Gastro-retentive Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Gastro-retentive Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Gastro-retentive Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Gastro-retentive Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Gastro-retentive Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Gastro-retentive Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Gastro-retentive Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Gastro-retentive Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Gastro-retentive Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Gastro-retentive Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Gastro-retentive Drug Delivery System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Sustained Release
  • Controlled Release (Zero-Order)
  • Delayed / Pulsatile Release
Applications
  • Anti-infective (H. pylori Eradication)
  • Gastroenterology (Peptic Ulcer, GERD)
  • Metabolic Disorders (Diabetes)
  • Cardiovascular (Hypertension)
  • Antiviral Therapy
Companies covered
  • Triastek, Inc.
  • Bostal Drug Delivery Co., Ltd.
  • Vivtex Corporation
  • Clexio Biosciences Ltd.
  • Medimetrics Personalized Drug Delivery, Inc.
  • Lonza Group AG
  • Catalent, Inc.
  • Evonik Industries AG
  • Colorcon, Inc.
  • Quotient Sciences
  • AbbVie Inc.
  • AstraZeneca plc
  • GlaxoSmithKline plc (GSK)
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Lupin Limited
  • Dr. Reddy's Laboratories Ltd.
  • Cipla Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Gastro-retentive Drug Delivery System Market by Type
  3. 1.2.1 Global Gastro-retentive Drug Delivery System Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Sustained Release
  5. 1.2.3 Controlled Release (Zero-Order)
  6. 1.2.4 Delayed / Pulsatile Release
  7. 1.3 Gastro-retentive Drug Delivery System Market by Application
  8. 1.3.1 Global Gastro-retentive Drug Delivery System Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Anti-infective (H. pylori Eradication)
  10. 1.3.3 Gastroenterology (Peptic Ulcer, GERD)
  11. 1.3.4 Metabolic Disorders (Diabetes)
  12. 1.3.5 Cardiovascular (Hypertension)
  13. 1.3.6 Antiviral Therapy
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Gastro-retentive Drug Delivery System Market Dynamics
  1. 2.1 Gastro-retentive Drug Delivery System Industry Trends
  2. 2.2 Gastro-retentive Drug Delivery System Industry Drivers
  3. 2.3 Gastro-retentive Drug Delivery System Industry Opportunities and Challenges
  4. 2.4 Gastro-retentive Drug Delivery System Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Gastro-retentive Drug Delivery System Market Perspective (2021-2032)
  2. 3.2 Global Gastro-retentive Drug Delivery System Growth Trends by Region
  3. 3.2.1 Global Gastro-retentive Drug Delivery System Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Gastro-retentive Drug Delivery System Market Size by Region (2021-2026)
  5. 3.2.3 Global Gastro-retentive Drug Delivery System Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Gastro-retentive Drug Delivery System Revenue by Players
  2. 4.1.1 Global Gastro-retentive Drug Delivery System Revenue by Players (2021-2026)
  3. 4.1.2 Global Gastro-retentive Drug Delivery System Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Gastro-retentive Drug Delivery System Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Gastro-retentive Drug Delivery System Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Gastro-retentive Drug Delivery System Key Players Headquarters & Area Served
  7. 4.4 Global Gastro-retentive Drug Delivery System Players, Product Type & Application
  8. 4.5 Global Gastro-retentive Drug Delivery System Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Gastro-retentive Drug Delivery System Market CR5 and HHI
  11. 4.6.3 2025 Gastro-retentive Drug Delivery System Tier 1, Tier 2, and Tier 3
5 Gastro-retentive Drug Delivery System Market Size by Type
  1. 5.1 Global Gastro-retentive Drug Delivery System Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Gastro-retentive Drug Delivery System Revenue by Type (2021-2032)
  3. 5.3 Global Gastro-retentive Drug Delivery System Revenue Market Share by Type (2021-2032)
6 Gastro-retentive Drug Delivery System Market Size by Application
  1. 6.1 Global Gastro-retentive Drug Delivery System Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Gastro-retentive Drug Delivery System Revenue by Application (2021-2032)
  3. 6.3 Global Gastro-retentive Drug Delivery System Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Triastek, Inc.
  2. 7.1.1 Triastek, Inc. Company Information
  3. 7.1.2 Triastek, Inc. Business Overview
  4. 7.1.3 Triastek, Inc. Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Triastek, Inc. Gastro-retentive Drug Delivery System Product Portfolio
  6. 7.1.5 Triastek, Inc. Recent Developments
  7. 7.2 Bostal Drug Delivery Co., Ltd.
  8. 7.2.1 Bostal Drug Delivery Co., Ltd. Company Information
  9. 7.2.2 Bostal Drug Delivery Co., Ltd. Business Overview
  10. 7.2.3 Bostal Drug Delivery Co., Ltd. Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Bostal Drug Delivery Co., Ltd. Gastro-retentive Drug Delivery System Product Portfolio
  12. 7.2.5 Bostal Drug Delivery Co., Ltd. Recent Developments
  13. 7.3 Vivtex Corporation
  14. 7.3.1 Vivtex Corporation Company Information
  15. 7.3.2 Vivtex Corporation Business Overview
  16. 7.3.3 Vivtex Corporation Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Vivtex Corporation Gastro-retentive Drug Delivery System Product Portfolio
  18. 7.3.5 Vivtex Corporation Recent Developments
  19. 7.4 Clexio Biosciences Ltd.
  20. 7.4.1 Clexio Biosciences Ltd. Company Information
  21. 7.4.2 Clexio Biosciences Ltd. Business Overview
  22. 7.4.3 Clexio Biosciences Ltd. Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Clexio Biosciences Ltd. Gastro-retentive Drug Delivery System Product Portfolio
  24. 7.4.5 Clexio Biosciences Ltd. Recent Developments
  25. 7.5 Medimetrics Personalized Drug Delivery, Inc.
  26. 7.5.1 Medimetrics Personalized Drug Delivery, Inc. Company Information
  27. 7.5.2 Medimetrics Personalized Drug Delivery, Inc. Business Overview
  28. 7.5.3 Medimetrics Personalized Drug Delivery, Inc. Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Medimetrics Personalized Drug Delivery, Inc. Gastro-retentive Drug Delivery System Product Portfolio
  30. 7.5.5 Medimetrics Personalized Drug Delivery, Inc. Recent Developments
  31. 7.6 Lonza Group AG
  32. 7.6.1 Lonza Group AG Company Information
  33. 7.6.2 Lonza Group AG Business Overview
  34. 7.6.3 Lonza Group AG Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Lonza Group AG Gastro-retentive Drug Delivery System Product Portfolio
  36. 7.6.5 Lonza Group AG Recent Developments
  37. 7.7 Catalent, Inc.
  38. 7.7.1 Catalent, Inc. Company Information
  39. 7.7.2 Catalent, Inc. Business Overview
  40. 7.7.3 Catalent, Inc. Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Catalent, Inc. Gastro-retentive Drug Delivery System Product Portfolio
  42. 7.7.5 Catalent, Inc. Recent Developments
  43. 7.8 Evonik Industries AG
  44. 7.8.1 Evonik Industries AG Company Information
  45. 7.8.2 Evonik Industries AG Business Overview
  46. 7.8.3 Evonik Industries AG Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Evonik Industries AG Gastro-retentive Drug Delivery System Product Portfolio
  48. 7.8.5 Evonik Industries AG Recent Developments
  49. 7.9 Colorcon, Inc.
  50. 7.9.1 Colorcon, Inc. Company Information
  51. 7.9.2 Colorcon, Inc. Business Overview
  52. 7.9.3 Colorcon, Inc. Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Colorcon, Inc. Gastro-retentive Drug Delivery System Product Portfolio
  54. 7.9.5 Colorcon, Inc. Recent Developments
  55. 7.10 Quotient Sciences
  56. 7.10.1 Quotient Sciences Company Information
  57. 7.10.2 Quotient Sciences Business Overview
  58. 7.10.3 Quotient Sciences Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Quotient Sciences Gastro-retentive Drug Delivery System Product Portfolio
  60. 7.10.5 Quotient Sciences Recent Developments
  61. 7.11 AbbVie Inc.
  62. 7.11.1 AbbVie Inc. Company Information
  63. 7.11.2 AbbVie Inc. Business Overview
  64. 7.11.3 AbbVie Inc. Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  65. 7.11.4 AbbVie Inc. Gastro-retentive Drug Delivery System Product Portfolio
  66. 7.11.5 AbbVie Inc. Recent Developments
  67. 7.12 AstraZeneca plc
  68. 7.12.1 AstraZeneca plc Company Information
  69. 7.12.2 AstraZeneca plc Business Overview
  70. 7.12.3 AstraZeneca plc Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  71. 7.12.4 AstraZeneca plc Gastro-retentive Drug Delivery System Product Portfolio
  72. 7.12.5 AstraZeneca plc Recent Developments
  73. 7.13 GlaxoSmithKline plc (GSK)
  74. 7.13.1 GlaxoSmithKline plc (GSK) Company Information
  75. 7.13.2 GlaxoSmithKline plc (GSK) Business Overview
  76. 7.13.3 GlaxoSmithKline plc (GSK) Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  77. 7.13.4 GlaxoSmithKline plc (GSK) Gastro-retentive Drug Delivery System Product Portfolio
  78. 7.13.5 GlaxoSmithKline plc (GSK) Recent Developments
  79. 7.14 Novartis AG
  80. 7.14.1 Novartis AG Company Information
  81. 7.14.2 Novartis AG Business Overview
  82. 7.14.3 Novartis AG Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Novartis AG Gastro-retentive Drug Delivery System Product Portfolio
  84. 7.14.5 Novartis AG Recent Developments
  85. 7.15 Pfizer Inc.
  86. 7.15.1 Pfizer Inc. Company Information
  87. 7.15.2 Pfizer Inc. Business Overview
  88. 7.15.3 Pfizer Inc. Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Pfizer Inc. Gastro-retentive Drug Delivery System Product Portfolio
  90. 7.15.5 Pfizer Inc. Recent Developments
  91. 7.16 Sanofi S.A.
  92. 7.16.1 Sanofi S.A. Company Information
  93. 7.16.2 Sanofi S.A. Business Overview
  94. 7.16.3 Sanofi S.A. Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Sanofi S.A. Gastro-retentive Drug Delivery System Product Portfolio
  96. 7.16.5 Sanofi S.A. Recent Developments
  97. 7.17 Sun Pharmaceutical Industries Ltd.
  98. 7.17.1 Sun Pharmaceutical Industries Ltd. Company Information
  99. 7.17.2 Sun Pharmaceutical Industries Ltd. Business Overview
  100. 7.17.3 Sun Pharmaceutical Industries Ltd. Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Sun Pharmaceutical Industries Ltd. Gastro-retentive Drug Delivery System Product Portfolio
  102. 7.17.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  103. 7.18 Lupin Limited
  104. 7.18.1 Lupin Limited Company Information
  105. 7.18.2 Lupin Limited Business Overview
  106. 7.18.3 Lupin Limited Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Lupin Limited Gastro-retentive Drug Delivery System Product Portfolio
  108. 7.18.5 Lupin Limited Recent Developments
  109. 7.19 Dr. Reddy's Laboratories Ltd.
  110. 7.19.1 Dr. Reddy's Laboratories Ltd. Company Information
  111. 7.19.2 Dr. Reddy's Laboratories Ltd. Business Overview
  112. 7.19.3 Dr. Reddy's Laboratories Ltd. Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Dr. Reddy's Laboratories Ltd. Gastro-retentive Drug Delivery System Product Portfolio
  114. 7.19.5 Dr. Reddy's Laboratories Ltd. Recent Developments
  115. 7.20 Cipla Ltd.
  116. 7.20.1 Cipla Ltd. Company Information
  117. 7.20.2 Cipla Ltd. Business Overview
  118. 7.20.3 Cipla Ltd. Gastro-retentive Drug Delivery System Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Cipla Ltd. Gastro-retentive Drug Delivery System Product Portfolio
  120. 7.20.5 Cipla Ltd. Recent Developments
8 North America
  1. 8.1 North America Gastro-retentive Drug Delivery System Revenue (2021-2032)
  2. 8.2 North America Gastro-retentive Drug Delivery System Revenue by Type (2021-2032)
  3. 8.2.1 North America Gastro-retentive Drug Delivery System Revenue by Type (2021-2026)
  4. 8.2.2 North America Gastro-retentive Drug Delivery System Revenue by Type (2027-2032)
  5. 8.3 North America Gastro-retentive Drug Delivery System Revenue Share by Type (2021-2032)
  6. 8.4 North America Gastro-retentive Drug Delivery System Revenue by Application (2021-2032)
  7. 8.4.1 North America Gastro-retentive Drug Delivery System Revenue by Application (2021-2026)
  8. 8.4.2 North America Gastro-retentive Drug Delivery System Revenue by Application (2027-2032)
  9. 8.5 North America Gastro-retentive Drug Delivery System Revenue Share by Application (2021-2032)
  10. 8.6 North America Gastro-retentive Drug Delivery System Revenue by Country
  11. 8.6.1 North America Gastro-retentive Drug Delivery System Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Gastro-retentive Drug Delivery System Revenue by Country (2021-2026)
  13. 8.6.3 North America Gastro-retentive Drug Delivery System Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Gastro-retentive Drug Delivery System Revenue (2021-2032)
  2. 9.2 Europe Gastro-retentive Drug Delivery System Revenue by Type (2021-2032)
  3. 9.2.1 Europe Gastro-retentive Drug Delivery System Revenue by Type (2021-2026)
  4. 9.2.2 Europe Gastro-retentive Drug Delivery System Revenue by Type (2027-2032)
  5. 9.3 Europe Gastro-retentive Drug Delivery System Revenue Share by Type (2021-2032)
  6. 9.4 Europe Gastro-retentive Drug Delivery System Revenue by Application (2021-2032)
  7. 9.4.1 Europe Gastro-retentive Drug Delivery System Revenue by Application (2021-2026)
  8. 9.4.2 Europe Gastro-retentive Drug Delivery System Revenue by Application (2027-2032)
  9. 9.5 Europe Gastro-retentive Drug Delivery System Revenue Share by Application (2021-2032)
  10. 9.6 Europe Gastro-retentive Drug Delivery System Revenue by Country
  11. 9.6.1 Europe Gastro-retentive Drug Delivery System Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Gastro-retentive Drug Delivery System Revenue by Country (2021-2026)
  13. 9.6.3 Europe Gastro-retentive Drug Delivery System Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Gastro-retentive Drug Delivery System Revenue (2021-2032)
  2. 10.2 China Gastro-retentive Drug Delivery System Revenue by Type (2021-2032)
  3. 10.2.1 China Gastro-retentive Drug Delivery System Revenue by Type (2021-2026)
  4. 10.2.2 China Gastro-retentive Drug Delivery System Revenue by Type (2027-2032)
  5. 10.3 China Gastro-retentive Drug Delivery System Revenue Share by Type (2021-2032)
  6. 10.4 China Gastro-retentive Drug Delivery System Revenue by Application (2021-2032)
  7. 10.4.1 China Gastro-retentive Drug Delivery System Revenue by Application (2021-2026)
  8. 10.4.2 China Gastro-retentive Drug Delivery System Revenue by Application (2027-2032)
  9. 10.5 China Gastro-retentive Drug Delivery System Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Gastro-retentive Drug Delivery System Revenue (2021-2032)
  2. 11.2 Asia Gastro-retentive Drug Delivery System Revenue by Type (2021-2032)
  3. 11.2.1 Asia Gastro-retentive Drug Delivery System Revenue by Type (2021-2026)
  4. 11.2.2 Asia Gastro-retentive Drug Delivery System Revenue by Type (2027-2032)
  5. 11.3 Asia Gastro-retentive Drug Delivery System Revenue Share by Type (2021-2032)
  6. 11.4 Asia Gastro-retentive Drug Delivery System Revenue by Application (2021-2032)
  7. 11.4.1 Asia Gastro-retentive Drug Delivery System Revenue by Application (2021-2026)
  8. 11.4.2 Asia Gastro-retentive Drug Delivery System Revenue by Application (2027-2032)
  9. 11.5 Asia Gastro-retentive Drug Delivery System Revenue Share by Application (2021-2032)
  10. 11.6 Asia Gastro-retentive Drug Delivery System Revenue by Country
  11. 11.6.1 Asia Gastro-retentive Drug Delivery System Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Gastro-retentive Drug Delivery System Revenue by Country (2021-2026)
  13. 11.6.3 Asia Gastro-retentive Drug Delivery System Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Gastro-retentive Drug Delivery System Revenue (2021-2032)
  2. 12.2 SAMEA Gastro-retentive Drug Delivery System Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Gastro-retentive Drug Delivery System Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Gastro-retentive Drug Delivery System Revenue by Type (2027-2032)
  5. 12.3 SAMEA Gastro-retentive Drug Delivery System Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Gastro-retentive Drug Delivery System Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Gastro-retentive Drug Delivery System Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Gastro-retentive Drug Delivery System Revenue by Application (2027-2032)
  9. 12.5 SAMEA Gastro-retentive Drug Delivery System Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Gastro-retentive Drug Delivery System Revenue by Country
  11. 12.6.1 SAMEA Gastro-retentive Drug Delivery System Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Gastro-retentive Drug Delivery System Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Gastro-retentive Drug Delivery System Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst